Trade Viatris Inc. - VTRS CFD
Add to favourite- Summary
- Historical Data
Spread | 0.09 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 11.71 |
Open | 11.83 |
1-Year Change | 13.86% |
Day's Range | 11.83 - 12.11 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 11.72 | 0.05 | 0.43% | 11.67 | 11.90 | 11.67 |
Jul 24, 2024 | 11.65 | 0.08 | 0.69% | 11.57 | 11.74 | 11.48 |
Jul 23, 2024 | 11.45 | -0.14 | -1.21% | 11.59 | 11.60 | 11.39 |
Jul 22, 2024 | 11.62 | -0.08 | -0.68% | 11.70 | 11.76 | 11.52 |
Jul 19, 2024 | 11.80 | 0.04 | 0.34% | 11.76 | 11.82 | 11.61 |
Jul 18, 2024 | 11.74 | -0.02 | -0.17% | 11.76 | 12.11 | 11.70 |
Jul 17, 2024 | 11.79 | 0.46 | 4.06% | 11.33 | 11.86 | 11.29 |
Jul 16, 2024 | 11.34 | 0.41 | 3.75% | 10.93 | 11.38 | 10.89 |
Jul 15, 2024 | 10.96 | -0.23 | -2.06% | 11.19 | 11.20 | 10.92 |
Jul 12, 2024 | 11.20 | 0.03 | 0.27% | 11.17 | 11.38 | 11.16 |
Jul 11, 2024 | 11.15 | 0.21 | 1.92% | 10.94 | 11.16 | 10.81 |
Jul 10, 2024 | 10.85 | 0.10 | 0.93% | 10.75 | 10.93 | 10.69 |
Jul 9, 2024 | 10.77 | 0.25 | 2.38% | 10.52 | 10.93 | 10.43 |
Jul 8, 2024 | 10.59 | 0.28 | 2.72% | 10.31 | 10.59 | 10.30 |
Jul 5, 2024 | 10.30 | 0.05 | 0.49% | 10.25 | 10.31 | 10.10 |
Jul 3, 2024 | 10.33 | -0.07 | -0.67% | 10.40 | 10.46 | 10.30 |
Jul 2, 2024 | 10.40 | -0.22 | -2.07% | 10.62 | 10.62 | 10.29 |
Jul 1, 2024 | 10.55 | -0.01 | -0.09% | 10.56 | 10.74 | 10.50 |
Jun 28, 2024 | 10.59 | 0.11 | 1.05% | 10.48 | 10.68 | 10.46 |
Jun 27, 2024 | 10.44 | 0.09 | 0.87% | 10.35 | 10.54 | 10.28 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Viatris Inc. Company profile
Viatris (VTRS) is a global healthcare company. It was formed in 2020 through the merger of Pfizer’s (PFE) off-patent branded and generic medicines division Upjohn and pharmaceutical firm Mylan.
The merger of Mylan and Upjohn was announced in July 2019 and received final regulatory clearance in October 2020. Pfizer shareholders own 57% of Viatris and Mylan shareholders own 43%, according to the merger announcement. Viatris started trading on the Nasdaq Stock Exchange under the ticker VTRS in November 2020.
Viatris is headquartered in Canonsburg, Pittsburgh, US. The company is operational in over 165 countries and has global centres in Shanghai, China and Hyderabad, India.
Viatris operates about 40 manufacturing sites which produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients. The firm also produces numerous complex generics, biosimilars and global key brands.
Viatris offers treatment options across more than 10 major therapeutic areas covering a wide variety of non-communicable and infectious diseases. According to the company’s website, 50% of its total active pharmaceutical ingredient (API) capacity is devoted to antiretroviral (ARV), which is used against HIV infection.
Some of the well-known and key brands under Viatris are anxiety treatment drug Xanax, antidepressant Zoloft, anti-inflammatory drug Celebrex and erectile dysfunction therapy Viagra, among others. Viatris also offers global biosimilars franchises focused on the areas of oncology, immunology, endocrinology, ophthalmology and dermatology.
Industry: | Pharmaceuticals (NEC) |
1000 Mylan Boulevard
CANONSBURG
PENNSYLVANIA 15317
US
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com